|
CCNF expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60670032833821E-10 |
| Normal-vs-Stage2 |
8.377600E-04 |
| Normal-vs-Stage3 |
3.26629945313073E-10 |
| Normal-vs-Stage4 |
2.14400053266672E-10 |
| Stage1-vs-Stage2 |
6.251200E-01 |
| Stage1-vs-Stage3 |
6.115700E-03 |
| Stage1-vs-Stage4 |
9.75079999999684E-05 |
| Stage2-vs-Stage3 |
2.038400E-01 |
| Stage2-vs-Stage4 |
1.246400E-02 |
| Stage3-vs-Stage4 |
7.696500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.20980000000304E-05 |
| Normal-vs-Asian |
1.113370E-01 |
| Caucasian-vs-AfricanAmerican |
6.635900E-02 |
| Caucasian-vs-Asian |
3.434000E-01 |
| AfricanAmerican-vs-Asian |
2.507600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7715611723761E-16 |
| Normal-vs-Female |
4.66204852500596E-12 |
| Male-vs-Female |
4.594600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.079590E-02 |
| Normal-vs-Age(41-60Yrs) |
2.7770008514949E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63080660087189E-12 |
| Normal-vs-Age(81-100Yrs) |
6.097200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.070800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.049000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.229600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.445600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.929400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.592400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.698180E-02 |
| Normal-vs-Grade 2 |
3.51889961613949E-10 |
| Normal-vs-Grade 3 |
1.69264602334351E-12 |
| Normal-vs-Grade 4 |
1.45130000239746E-08 |
| Grade 1-vs-Grade 2 |
3.407600E-01 |
| Grade 1-vs-Grade 3 |
1.638160E-02 |
| Grade 1-vs-Grade 4 |
8.07750000000329E-05 |
| Grade 2-vs-Grade 3 |
1.683790E-02 |
| Grade 2-vs-Grade 4 |
2.043000E-04 |
| Grade 3-vs-Grade 4 |
3.800900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.22169996341626E-09 |
| Normal-vs-ccB subtype |
4.90385509976932E-13 |
| ccA subtype-vs-ccB subtype |
3.84450000001646E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77846626314704E-12 |
| Normal-vs-N1 |
6.589500E-04 |
| N0-vs-N1 |
2.034000E-02 |
|
|
